Literature DB >> 11180110

Human CD8(+) T cells expressing HLA-DR and CD28 show telomerase activity and are distinct from cytolytic effector T cells.

D E Speiser1, M Migliaccio, M J Pittet, D Valmori, D Liénard, F Lejeune, P Reichenbach, P Guillaume, I Lüscher, J C Cerottini, P Romero.   

Abstract

Cycling lymphocytes may express the enzyme telomerase which is involved in maintenance of telomere length and cell proliferation potential. In CD8(+) T cells freshly isolated from peripheral blood, we found that in vivo cycling cells expressed HLA-DR. Furthermore, CD28-positive cells are known to have longer telomeres than CD28-negative T cells. Therefore we used HLA-DR- and CD28-specific antibodies to sort CD8(+) T cells and measure telomerase activity ex vivo. Relatively high levels of telomerase activity were found in HLA-DR/CD28 double-positive cells. In contrast, HLA-DR-negative and CD28-negative cells had almost no telomerase activity. In summary, HLA-DR expression correlates with proliferation, and CD28 expression with proliferative potential. We have previously identified that ex vivo cytolytic CD8(+) T cells are CD56 (NCAM) positive. Here we show that HLA-DR(+) cells were rarely CD56(+) and vice versa. This demonstrates that telomerase-expressing and cytolytic CD8(+) T cells can be separated on the basis of the cell surface markers HLA-DR and CD56. Thus, activated CD8(+) T cells specialize and exert distinct functions correlating with surface molecule expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11180110     DOI: 10.1002/1521-4141(200102)31:2<459::aid-immu459>3.0.co;2-y

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  17 in total

1.  Human dendritic cells infected with the nonpathogenic Mopeia virus induce stronger T-cell responses than those infected with Lassa virus.

Authors:  Delphine Pannetier; Stéphanie Reynard; Marion Russier; Alexandra Journeaux; Noël Tordo; Vincent Deubel; Sylvain Baize
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation.

Authors:  Jaikumar Duraiswamy; Riccardo Turrini; Aspram Minasyan; David Barras; Isaac Crespo; Alizée J Grimm; Julia Casado; Raphael Genolet; Fabrizio Benedetti; Alexandre Wicky; Kalliopi Ioannidou; Wilson Castro; Christopher Neal; Amandine Moriot; Stéphanie Renaud-Tissot; Victor Anstett; Noémie Fahr; Janos L Tanyi; Monika A Eiva; Connor A Jacobson; Kathleen T Montone; Marie Christine Wulff Westergaard; Inge Marie Svane; Lana E Kandalaft; Mauro Delorenzi; Peter K Sorger; Anniina Färkkilä; Olivier Michielin; Vincent Zoete; Santiago J Carmona; Periklis G Foukas; Daniel J Powell; Sylvie Rusakiewicz; Marie-Agnès Doucey; Denarda Dangaj Laniti; George Coukos
Journal:  Cancer Cell       Date:  2021-11-04       Impact factor: 31.743

3.  Prediction of tumor recurrence by distinct immunoprofiles in liver transplant patients based on mass cytometry.

Authors:  Xuyong Wei; Wentao Xie; Weiwei Yin; Mengfan Yang; Abdul Rehman Khan; Renyi Su; Wenzhi Shu; Binhua Pan; Guanghan Fan; Kun Wang; Fan Yang; Di Lu; Changbiao Li; Linhui Pan; Beini Cen; Haiyang Xie; Li Zhuang; Shusen Zheng; Xun Zeng; Wei Chen; Xiao Xu
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

4.  Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART.

Authors:  Barbara Ensoli; Stefania Bellino; Antonella Tripiciano; Olimpia Longo; Vittorio Francavilla; Simone Marcotullio; Aurelio Cafaro; Orietta Picconi; Giovanni Paniccia; Arianna Scoglio; Angela Arancio; Cristina Ariola; Maria J Ruiz Alvarez; Massimo Campagna; Donato Scaramuzzi; Cristina Iori; Roberto Esposito; Cristina Mussini; Florio Ghinelli; Laura Sighinolfi; Guido Palamara; Alessandra Latini; Gioacchino Angarano; Nicoletta Ladisa; Fabrizio Soscia; Vito S Mercurio; Adriano Lazzarin; Giuseppe Tambussi; Raffaele Visintini; Francesco Mazzotta; Massimo Di Pietro; Massimo Galli; Stefano Rusconi; Giampiero Carosi; Carlo Torti; Giovanni Di Perri; Stefano Bonora; Fabrizio Ensoli; Enrico Garaci
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

Review 5.  Profile of a serial killer: cellular and molecular approaches to study individual cytotoxic T-cells following therapeutic vaccination.

Authors:  Emanuela M Iancu; Petra Baumgaertner; Sébastien Wieckowski; Daniel E Speiser; Nathalie Rufer
Journal:  J Biomed Biotechnol       Date:  2010-11-14

6.  Regulation of HLA-DR and co-stimulatory molecule expression on natural killer T cells by granulocyte-macrophage colony-stimulating factor.

Authors:  Kamal U Saikh; Teri Kissner; Robert G Ulrich
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

7.  HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype.

Authors:  Asier Sáez-Cirión; Christine Lacabaratz; Olivier Lambotte; Pierre Versmisse; Alejandra Urrutia; Faroudy Boufassa; Françoise Barré-Sinoussi; Jean-François Delfraissy; Martine Sinet; Gianfranco Pancino; Alain Venet
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-11       Impact factor: 11.205

8.  Comparison of anti-CD3 and anti-CD28-coated beads with soluble anti-CD3 for expanding human T cells: differing impact on CD8 T cell phenotype and responsiveness to restimulation.

Authors:  Yixin Li; Roger J Kurlander
Journal:  J Transl Med       Date:  2010-10-26       Impact factor: 5.531

9.  Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy.

Authors:  Laurence Weiss; Christophe Piketty; Lambert Assoumou; Céline Didier; Laure Caccavelli; Vladimira Donkova-Petrini; Yves Levy; Pierre-Marie Girard; Marianne Burgard; Jean-Paul Viard; Christine Rouzioux; Dominique Costagliola
Journal:  PLoS One       Date:  2010-07-21       Impact factor: 3.240

10.  Effect of ageing on CMV-specific CD8 T cells from CMV seropositive healthy donors.

Authors:  María Luisa Pita-Lopez; Inmaculada Gayoso; Olga DelaRosa; Javier G Casado; Corona Alonso; Elisa Muñoz-Gomariz; Raquel Tarazona; Rafael Solana
Journal:  Immun Ageing       Date:  2009-08-28       Impact factor: 6.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.